Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2004
11/04/2004CA2523260A1 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
11/04/2004CA2522904A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004CA2522819A1 Polyvalent protein complex
11/04/2004CA2522730A1 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
11/04/2004CA2522718A1 A novel method of modulating bone-related activity
11/04/2004CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004CA2522637A1 Modified irna agents
11/04/2004CA2522560A1 Antisense modulation of apolipoprotein c-iii expression
11/04/2004CA2522497A1 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004CA2522359A1 Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions
11/04/2004CA2522349A1 Protected monomers
11/04/2004CA2522184A1 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004CA2522172A1 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004CA2520750A1 Orthogonal aminoacyl-trna synthetase
11/03/2004EP1473367A1 Means and methods for diagnosing and treating affective disorders
11/03/2004EP1473299A2 Isolation of nucleid acids
11/03/2004EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004EP1472373A2 Methods for making polynucleotides and purifying double-stranded polynucleotides
11/03/2004EP1472372A1 METHODS FOR THE PREPARATION OF CHEMICALLY MISAMINOACYLATED tRNA VIA PROTECTIVE GROUPS
11/03/2004EP1472348A2 Light activated gene transduction using ultraviolet light for cell targeted gene delivery
11/03/2004EP1472274A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/03/2004EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004EP1472266A2 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents
11/03/2004EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004EP1268508A4 Quality control reagents for nucleic acid microarrays
11/03/2004EP0769556B1 Gene coding for a heat stable beta-amylase from barley
11/03/2004CN1542143A Colorectal cancer prognostics
11/03/2004CN1542125A Streptomyces nanningensis
11/03/2004CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004CN1173989C DNA sequence of dendrobium and method for identifying its variety or judging if it is true or false
11/02/2004US6812382 Plant genes encoding chloroplast division proteins
11/02/2004US6812342 Diffuse across cell membranes of fully intact cells and regenerate their parent molecules by cellular esterase hydrolysis
11/02/2004US6812339 Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
11/02/2004US6812334 Detecting/separating nucleic acids for diagnosis of genetic/bacterial/viral diseases; kits; nanofabrication
11/02/2004US6812327 Neutrokine-alpha polypeptides
11/02/2004US6812210 Urocortin-III and uses thereof
11/02/2004US6811982 Analysis of nucleotide sequence methylation patterns; obtain genomic nucleotide sequences, incubate with sodium bisulfite, expose to primers, amplify, isolate amplification products, determine concentration of alleles
11/02/2004US6811981 Release of intracellular material
11/02/2004US6811980 Fixing nucleotide sequences to solid support; obtain nucleotide sequences, incubate with oxygen chemical intermediate, monitor solid suport for presence of fixed nucleotide sequences
11/02/2004US6811979 Fluorescent nucleobase conjugates having anionic linkers
11/02/2004US6811977 Rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping
11/02/2004US6811975 Phosphorothioate oligonucleotides having modified internucleoside linkages
11/02/2004US6811783 Immunogenic compositions for protection against chlamydial infection
11/02/2004CA2176348C Hybridization probes for nucleic acid detection, universal stems, methods and kits
11/02/2004CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/01/2004CA2463716A1 Rapid extraction of rna from cells and tissues
10/2004
10/28/2004WO2004092399A2 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism
10/28/2004WO2004092397A2 Tmprss2 regulatory sequences and uses thereof
10/28/2004WO2004092396A2 Flap endonuclease 1 (fen1) regulatory sequences and uses thereof
10/28/2004WO2004092393A1 Purification of polypeptides
10/28/2004WO2004092391A2 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
10/28/2004WO2004092384A2 Means and methods for diagnosing and treating affective disorders
10/28/2004WO2004092340A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
10/28/2004WO2004092337A2 Promoting cardiac cell differentiation
10/28/2004WO2004092328A2 Novel beta-tubulin protein of candida glabrata and methods for its use
10/28/2004WO2004092327A2 Method of generating size standard nucleic acids
10/28/2004WO2004092324A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
10/28/2004WO2004092191A2 Polymeric oligonucleotide prodrugs
10/28/2004WO2004092051A2 Organic polymeric material an method for the production thereof
10/28/2004WO2004091526A2 Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies
10/28/2004WO2004091515A2 iRNA CONJUGATES
10/28/2004WO2004074439A3 An expression cassette and vector for transient or stable expression of exogenous molecules
10/28/2004WO2004065938A3 Human osteoporosis gene
10/28/2004WO2004060145A3 Isolation and identification of cross-reactive t cells
10/28/2004WO2004046339A3 Caged sensors, regulators and compounds and uses thereof
10/28/2004WO2004029274A3 Method for generating an immune response and reagents therefor
10/28/2004WO2003100020A3 Methods and constructs for high yield expression of clostripain
10/28/2004WO2003042657A3 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
10/28/2004US20040216190 Expression vector for transfer and generation of freeze, herbicide, drought, heat and disease resistant plants; tissue engineering
10/28/2004US20040216178 Knockout expression vector which targets preferential ocogenic gene for use as tool in treatment of cell proliferative diseases
10/28/2004US20040215031 Functionalized silicon compounds and methods for their synthesis and use
10/28/2004US20040215012 nucleosides; fluorescent in situ hybridization; for production of combinatorial libraries
10/28/2004US20040215010 Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
10/28/2004US20040215009 for affinity chromatography and screening of proteomes or combinatorial libraries; solid phase synthesis
10/28/2004US20040215006 Oligonucleotide sequences for treatment and prevention of cell proliferative and skin disorders; gene expression inhibition; antisense agents
10/28/2004US20040214349 Molecular marker
10/28/2004US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
10/28/2004US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004US20040214285 HIV-specific fusion proteins and therapeutic and diagnostic methods for use
10/28/2004US20040214282 Prokaryotic collagen-like proteins and uses thereof
10/28/2004US20040214279 Insect monoamine transporter and methods of use thereof
10/28/2004US20040214276 host cells containing expression systems for production of nucleotide diphosphate 6-deoxy-mycarose; polyketides
10/28/2004US20040214272 Nucleic acid molecules and other molecules associated with plants
10/28/2004US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004US20040214239 Functional coupling of T1Rs and T2Rs by GI proteins, and cell-based assays for the identification of T1R and T2R modulators
10/28/2004US20040214223 Methods and agents for screening for compounds capable of modulating VEGF expression
10/28/2004US20040214219 Nucleotide sequences which code for the tal gene
10/28/2004US20040214199 comprising protected hydrazino, oxyamino and carbonyl-based groups biochemical immobilization; solid phase synthesis
10/28/2004US20040214196 Using ligation and amplification to detect preferential sequences nucleic acids; diagnosing infection and cell proliferative disorders
10/28/2004US20040214195 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/28/2004US20040214178 Transgenic cells comprising viral expression for use as part of assay to determine specific antiviral activity of inhibitors in standard dose responses; drug screening and viricides
10/28/2004US20040214161 Using nucleotide sequence amplification to identify herpes virus sequence in bodily fluids; diagnosing//prognosing cell proliferative disorders
10/28/2004US20040214019 Covalently attaching to the surface a functionalized silicon compound include at least one activated silicon group and at least one derivatizable functional group
10/28/2004US20040213808 immunogenic compositions containing as active ingredients recombinantly-produced forms of truncated flavivirus envelope and non-structural glycoproteins; may also include an adjuvant, such as saponin or a saponin-like material
10/28/2004US20040213788 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
10/28/2004CA2522985A1 Means and methods for diagnosing and treating affective disorders